Home/Filings/4/0000950170-24-046178
4//SEC Filing

Sullivan Timothy Eugene 4

Accession 0000950170-24-046178

CIK 0001492422other

Filed

Apr 18, 8:00 PM ET

Accepted

Apr 19, 7:27 PM ET

Size

6.5 KB

Accession

0000950170-24-046178

Insider Transaction Report

Form 4
Period: 2024-04-18
Sullivan Timothy Eugene
Chief Financial Officer
Transactions
  • Gift

    Common Stock

    2024-04-1814,16479,174 total
  • Gift

    Common Stock

    2024-04-18+14,16470,396 total(indirect: By Trust)
Footnotes (1)
  • [F1]On April 18, 2024, the reporting person transferred 14,164 shares to The Timothy E Sullivan Irrevocable Trust of 2023. Patrick O. Collins is the trustee of The Timothy E Sullivan Irrevocable Trust of 2023. The reporting person disclaims beneficial ownership over the shares held by The Timothy E Sullivan Irrevocable Trust of 2023 except to the extent of his pecuniary interest therein.

Documents

1 file

Issuer

Apellis Pharmaceuticals, Inc.

CIK 0001492422

Entity typeother

Related Parties

1
  • filerCIK 0001707000

Filing Metadata

Form type
4
Filed
Apr 18, 8:00 PM ET
Accepted
Apr 19, 7:27 PM ET
Size
6.5 KB